Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

By M. Hooning, A. Botma, B. Aleman, Margreet H. A. Baaijens, H. Bartelink, J. Klijn, Carolyn Taylor, F. V. van Leeuwen. Journal of the National Cancer Institute, 2007

865 citations recorded by the source corpus.

Subfields: Cancer Research, Cardiology and Cardiovascular Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/0973532347bf3c315e84e8e16aab59c9f53060a3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

J. Plana
P. Thavendiranathan
F. Poulin
Ki-Dong Lim
A. Woo
T. Marwick

Citations in the corpus

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, neutral): “treated with both left breast radiotherapy and cardiotoxic chemotherapy, suggesting a synergistic effect on cardiac risk.(82) Marked interstitial myocardial fibrosis is common in radiotherapy-induced cardiotoxicity, with lesions of variable volumes and distribution.”
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer (2010, neutral): “Hooning et al. (1) studied the treatment-speciﬁc incidence of cardiovascular disease in 4,414 patients in the Dutch late-effects breast cancer cohort who had survived 10 years after treatment.”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, neutral): “treated with both left breast radiotherapy and cardiotoxic chemotherapy, suggesting a synergistic effect on cardiac risk.(82) Marked interstitial myocardial fibrosis is common in radiotherapy-induced cardiotoxicity, with lesions of variable volumes and distribution.”
Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. (2014, background): “However, cardiac toxicity (cardiotoxicity) from cancer therapy has become a leading cause of morbidity and mortality in survivors (3,4).”